Aim of our work was firstly to determine the prevalence of anti-coxsackievirus antibodies
Introduction. Enteroviruses are distributed worldwide with the highest frequency in temperate climate. Their circulation increases during summer and early autumn [1] . Enterovirus infections are usually unapparent. They manifest broad spectrum of symptoms like mild nonspecific febrile illness or infection of upper respiratory tract. In some cases, particularly in newborns or immunodeficient patients, they may cause serious illnesses like aseptic meningitis, encephalitis and myocarditis, they may rarely give rise to serious newborn sepsis or paralytic poliomyelitis [2] [3] [4] . Enteroviruses also play a role in etiology of chronic illnesses, e. g. dilated cardiomyopathy and infections by these viruses may lead to development of type 1 diabetes (T1D) [5, 6] . These viruses may cause severe or fatal illnesses of newborns [7] . They have been detected in amniotic fluid, placenta and in tissue of the fetus [8] . These infections are linked to various congenital anomalies, stillborn fetuses or abortions [8] .
Several experimental infection studies [7, 9, 10] show effects of coxsackievirus infections on the course of gravidity, stillbirths, premature birth and higher death rate in female mice infected in later stages of the gravidity.
Our aim was to study the circulation of coxsackieviruses in pregnant women, and to investigate possibility of vertical transmission to the fetus by studying the presence of enteroviral RNA in the organs of the stillborn fetuses.
Material and methods. Measurement of antibody titers in pregnant women by the Virus Neutralization Test (VNT). Antibodies were detected and measured by the method described by [11] . Titers of antibodies against Coxsackieviruses: B1 (CVB1) strain Conn; B2 (CVB2) strain Ohio; B3 (CVB3) strain Nancy; B4 (CVB4) strain JVB; B5 (CVB5) strain Faulkner; B6 (CVB6) strain Schmitt (CVB6); A7 (CVA7) strain Parker, and A9 (CVA9) strain Griggs were determined in paired samples of sera from gravid women. Rise in antibody titers in the paired sera showed acute or recent infection.
A 4 fold log 2 in paired samples increase of anticoxsackievirus antibodies by in sera was the marker of the current infection.
Detection of viral RNA in the dead fetuses of the experimental infected gravid mice.
CD-1 female mice were used for experimental infection. Permission for the animal work was obtained from the Ethics Committee of the Slovak Health University and the State Veterinary and Food Control Authority of the Slovak Republic. 9 pregnant mice were experimentally infected with CVB4 strain E2. Infectious dose of 1×10 7 TCID 50 in 0,5 ml suspension of CVB4-E2 was given as described by [12] by oral gavage. Female gravid mice were infected during the three different gestational periods at day 4, 10 and 17. We selected the pregnant mouse infected with virus in the second week gestation, which was lethargic and stopped showing gain in weight, and was sick to give birth. This mouse was sacrificed, dead fetuses were removed, and organs were studied for presence of RNA.
Detection of viral RNA. RNA Mini Kit («Invitro-gen», USA) was used for isolation of RNA from prepared organ suspensions. SuperScript™ One-Step RT-PCR with Platinum® Taq («Invitrogen») kit was used for the reverse transcription (RT) reaction. Nested reaction was performed using the same kit. The primers, RT and the nested reaction have been described by [12] .
Results and discussion. Most of the seroepidemiological studies involving CVB infections during pregnancy are related to their association to T1D. The involvement of enterovirus infections as an environmental trigger of type 1 diabetes (T1D) and maternal infection during gravidity increases risk of T1D development and progress in children in age 0-14 has been studied by [13, 14] . Serological studies have shown the presence of anti-CVB IgM antibodies in pregnant women suggesting that coxsackievirus infection during pregnancy can be the cause of miscarriages and also linked to development of T1D in children whose mothers overcame infection during gravidity [15, 16] .
Our aim was to analyze the circulation and current CVB infections in pregnant women. As observed in Table 1 serotype CVB4 was dominantly circulating in the studied population, followed by CVB3, CVA9, CVB5, CVB2 and CVB1. CVB6 prevalence is the least frequent. Furthermore as seen from Fig. 1 : 25.35 % of the studied cases had already encountered with five of chosen coxsackievirus serotypes, 1.84 % against all of studied serotypes and 2.3 % of gravid women did not have antibodies against any of observed serotype. Current infections was noted in 30 out of 217 (13.82 %) investigated pregnant women.
Transmission of virus from mother to suckling mice, primarily in later stages of gestation, has been considered to be possible as shown by [7] . We observed presence of RNA in all the dead fetuses in the experimentally infected dams in the 2 nd week of gestation. +/total = number of positive sera/total number of sera studied. Table 1 Prevalence of coxsackievirus serotypes in the studied cases in the placenta and the navelwort of each of the unborn fetuses and in intestine of the most of dissected fetuses of the experimentally infected sick dam. Both were detected by RT-PCR.
The results of our experimental study suggest that the infection had an effect on the fetuses in the second week of gestation. Moreover we have shown that virus may be transferred on the progeny during intrauterinal development. This aspect should be studied further.
Conclusions. Serological study shows prevalence of coxsackievirus antibodies in gravid women in Slovak Republic. Our experimental infection study shows that the infection in the second week of gestation and may be a result of transfer of the virus from mother to fetus. We conclude that systematic follow up of CV infections and their consequences on the offspring, fetus and pregnancy should be closely studied. These studies infer the importance of a possibility of including coxsackieviruses in the screening of the viral infections during pregnancy.
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